eFront, the private markets platform by Aladdin, integrates Preqin capabilities to build data-rich market context and powerful analytics into investor decision making BlackRock Aladdin has integrated ...

This week, the return of Alabama forward Charles Bediako after spending time in NBA’s G-League has been one of, if not the most talked about story in all of college basketball. Bediako is the latest ...

Objectives To compare primary care for depression among patients detected in the first 21 months of the SARS-CoV-2 pandemic to patients detected pre-pandemic, and examine whether depression care was ...

Abstract: This article examines the interplay between the retailer’s strategic information sharing and the manufacturer’s quality decisions under two decision sequences: pre-quality and post-quality ...

Status: UnconfirmedA potential issue that we haven't yet confirmed as a bugA potential issue that we haven't yet confirmed as a bugType: Bug The code in src/app/page.tsx uses Array.reduce to build an ...

Foster cross-agency coordination on hazard mitigation and climate adaptation Require consideration of future risk in hazard mitigation investments Direct hazard mitigation funding where the negative ...

Whatever your fitness goal, your decisions matter, and exercisers are faced with a LOT of decisions to make! For example, should you follow a split or full-body routine, do high-intensity intervals or ...

While Mercury, the wily planet of communication, doesn’t station retrograde until November 9th, we’re locked and loaded to experience a lovely little preview of its hijinks. We’re talking shadows, ...

The evolving regulatory landscape has increasingly recognized the value of real-world data (RWD) in enhancing drug safety surveillance across the clinical development lifecycle. Enabled by frameworks ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

During a live event, Neil M. Iyengar, MD, discusses how genomic risk scores and menopausal status guide complex adjuvant therapy choices in breast cancer. Hormone receptor-positive, HER2-negative is ...